["Entrapment" hyperthyroidism resulting from thyroid opotherapy].
D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D005260:Female; D006042:Goiter / Q000188:drug therapy; D006111:Graves Disease / Q000139:chemically induced*; D006801:Humans; D007455:Iodine / Q000009:adverse effects; D008875:Middle Aged; D013963:Thyroid Hormones / Q000009:adverse effects*; D014284:Triiodothyronine / Q000009:adverse effects
D013956:Antithyroid Agents; D013963:Thyroid Hormones; D014284:Triiodothyronine; D007455:Iodine
Hyperthyroïdie "d'entraînement" par opothérapie thyroïdienne.